Medicare Enrolled
Dr. Jeffrey Uzzilia, MD
Cardiovascular Disease · Albany, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Uzzilia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Uzzilia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Uzzilia
Dr. Jeffrey Uzzilia is a cardiovascular disease specialist in Albany, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Uzzilia performed 21,261 Medicare services across 6,770 unique beneficiaries.
Between the years covered by Open Payments, Dr. Uzzilia received a total of $2,189 from 16 pharmaceutical and/or device companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Uzzilia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in NY
$2,189 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,261
Medicare services
Top 0% in NY for cardiovascular disease
6,770
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
7,480 | $0 | $1 |
| Inclisiran injection (Leqvio) for cholesterol | 4,828 | $9 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,624 | $85 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,596 | $10 | $30 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
592 | $43 | $113 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
407 | $8 | $14 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
328 | $6 | $16 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
317 | $91 | $150 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
290 | $10 | $21 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
281 | $8 | $15 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
267 | $140 | $382 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
265 | $45 | $140 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
261 | $38 | $80 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
225 | $13 | $27 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
185 | $16 | $32 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
173 | $7 | $13 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 172 | $407 | $583 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
158 | $326 | $853 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
152 | $61 | $149 |
| Troponin blood test A blood test that measures the amount of troponin protein in your body. Troponin is released into the blood when heart muscle is damaged. |
136 | $12 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
111 | $131 | $341 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
100 | $91 | $226 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
90 | $130 | $350 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
86 | $1,265 | $3,200 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
86 | $99 | $259 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
86 | $45 | $110 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
85 | $8 | $17 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
83 | $29 | $80 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
82 | $2 | $2 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
75 | $13 | $26 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $111 | $300 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
62 | $18 | $50 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
62 | $629 | $1,500 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
57 | $35 | $90 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
54 | $36 | $90 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
52 | $9 | $18 |
| CT scan of chest blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest. |
40 | $193 | $560 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
35 | $152 | $400 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
33 | $217 | $651 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $43 | $110 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $10 | $28 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $213 | $540 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
18 | $1 | $2 |
| New patient office visit, complex (60-74 min) | 16 | $141 | $375 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
15 | $8 | $20 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
13 | $181 | $460 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
13 | $39 | $100 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
13 | $18 | $45 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
11 | $118 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
65.2% medium
33.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,189
Total received (2018-2024)
Avg $313/year across 7 years
Top 48% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
169
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,164 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$710
2023
$444
2022
$373
2021
$327
2020
$104
2019
$151
2018
$80
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$225
Kiniksa Pharmaceuticals International, plc
$180
SCPHARMACEUTICALS INC.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
E.R. Squibb & Sons, L.L.C.
$50
PFIZER INC.
$20
Amgen Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Lexicon Pharmaceuticals, Inc.
$15
Top 3 companies account for 70.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,081
E.R. Squibb & Sons, L.L.C.
$233
Kiniksa Pharmaceuticals International, plc
$180
Kiniksa Pharmaceuticals, Ltd.
$123
SCPHARMACEUTICALS INC.
$115
PFIZER INC.
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Janssen Pharmaceuticals, Inc
$97
Alnylam Pharmaceuticals Inc.
$29
Currax Pharmaceuticals LLC
$25
Amgen Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Lexicon Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme Corporation
$14
SANOFI-AVENTIS U.S. LLC
$13
BRACCO DIAGNOSTICS INC.
$12
Top 3 companies account for 68.3% of all-time payments
Associated products mentioned in payments ›
Arcalyst · CAMZYOS · CARDIOGEN · ELIQUIS · ENTRESTO · FUROSCIX · JARDIANCE · LEQVIO · MULTAQ · NEXLETOL · ONPATTRO · Repatha · VERQUVO · VYNDAQEL · WAINUA · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
101
Per 100K population
32.0
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
4.6 mi
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Uzzilia is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Uzzilia experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Uzzilia performed 7,480 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Uzzilia receive payments from pharmaceutical companies?
Yes. Dr. Uzzilia received a total of $2,189 from 16 companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Uzzilia's costs compare to other cardiologists in Albany?
Dr. Uzzilia's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Uzzilia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Albany
Browse cardiologists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Kiniksa Pharmaceuticals International, plc Payments to Doctors
See all physicians who received payments from Kiniksa Pharmaceuticals International, plc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology